On April 7, 2020, the Board of Spring Bank Pharmaceuticals, Inc. approved the appointment of Lori Firmani, the Company's current Vice President, Finance, as the Company's principal financial officer and principal accounting officer, effective as of April 24, 2020, which is the effective date of the resignation of Jonathan Freve as the Company's Chief Financial Officer and Treasurer. Mr. Freve informed the Company on April 7, 2020 that he is resigning to pursue a chief financial officer opportunity at another biopharmaceutical development company. Ms. Firmani has served as the Company's Vice President, Finance since January 2020 and had previously served as the Company's Corporate Controller since January 2016.

From June 2015 to January 2016, she served as the Controller of Genzyme External Manufacturing of Sanofi Genzyme.